Senior Manager, Investor Relations

The Resmed Investor Relations (IR) team is responsible for building and maintaining effective two-way communications between Resmed and the investment community, including shareholders and other institutional investors, sell-side analysts, and other financial stakeholders. This dialogue facilitates enhanced understanding and awareness of Resmed’s strategy, financial performance, and long-term growth opportunities to ultimately achieve a fair valuation for the company. 

ROLE: 

Resmed is looking for a Senior Manager, IR to serve as a key point of contact with the investment community. The Senior Manager, IR will work in partnership with the Chief Investor Relations Officer (CIRO) to build and execute a strategic IR marketing plan, including, but not limited to, targeting analysis, annual goal setting, event strategy and logistics coordination, presentation development, and related internal process management and reporting. This person will also support broader IR team initiatives, including quarterly earnings and other IR-related activities. This is a highly visible and critical role that will partner and collaborate with Resmed’s executive leadership team and multiple other functions to ensure we are communicating our Resmed story as effectively and efficiently as possible. 

KEY RESPONSIBILITIES:

• Partner with the CIRO to set Resmed’s annual IR marketing strategy, focused on optimizing across geographies, event forums (e.g., conferences, non-deal roadshows, bus tours), and management attendance to ensure effective engagement with shareholders, target investment firms, and sell side analysts. 

• Lead targeting analysis, leveraging third party tools and relationships. Provide in-depth intelligence on prospective investors as needed. Maintain global investor targeting documents to inform meeting prioritization. 

• ​ Actively manage Resmed’s IR marketing calendar and related processes to deliver efficient planning and logistics coordination with internal and external constituents. 

• Partner with the CIRO to establish annual goals and measurement programs related to IR marketing effectiveness. 

• Support IR team development of key messages, corporate narrative, and investor presentations to facilitate investment community engagement. 

• Maintain relationships with third-party service providers and advisors to ensure Resmed’s IR program is utilizing best-in-class products, services, and tools. 

• Support IR and legal team efforts to ensure Resmed’